Spots Global Cancer Trial Database for tmz
Every month we try and update this database with for tmz cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma | NCT00727506 | Glioma | BIBW 2992 TMZ BIBW 2992 plus ... | 18 Years - | Boehringer Ingelheim | |
| Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma | NCT04091503 | Glioma, Maligna... Gliosarcoma Astrocytoma of ... | Intranasal Modi... | 21 Years - 70 Years | Center Trials & Treatment Europe | |
| Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme | NCT05589961 | Glioblastoma Mu... | TMZ | 18 Years - 75 Years | The Second Hospital of Hebei Medical University | |
| LAM561 With RT and TMZ for Adults With Glioblastoma | NCT04250922 | Primary Gliobla... Glioblastoma Mu... | LAM561 TMZ RT | 18 Years - 75 Years | Laminar Pharmaceuticals | |
| A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma | NCT03150862 | Brain and Centr... | Pamiparib TMZ Radiation | 18 Years - | BeiGene | |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | NCT04430842 | Astrocytoma Brain Cancer Brain Metastase... Bladder Cancer Breast Cancer Cervical Cancer Cholangiocarcin... Colorectal Canc... Esophagus Cance... Gastric Cancer Head and Neck C... Kidney Cancer Liver Cancer Lung Cancer Melanoma Ovarian Cancer Pancreatic Canc... Pleural Mesothe... Prostate Cancer Sarcoma Tongue Cancer Thymic Carcinom... Urinary Tract C... | QBS10072S | 18 Years - | Quadriga Biosciences, Inc. | |
| Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma | NCT04091503 | Glioma, Maligna... Gliosarcoma Astrocytoma of ... | Intranasal Modi... | 21 Years - 70 Years | Center Trials & Treatment Europe | |
| A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma | NCT00395070 | Metastatic Mela... | Allovectin-7® Dacarbazine (DT... Temozolomide (T... | 18 Years - | Vical | |
| Study of Temozolomide to Treat Newly Diagnosed Brain Metastases | NCT00717275 | Brain Metastase... | Temozolomide | 18 Years - | University of Florida | |
| Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma | NCT01260103 | Optic Nerve Gli... | Temozolomide ANP Therapy | 6 Months - 18 Years | Burzynski Research Institute | |
| Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma | NCT01364064 | Glioblastoma | TMZ | - | King Faisal Specialist Hospital & Research Center | |
| 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients | NCT00504660 | Anaplastic Glio... Glioblastoma Mu... Brain Cancer | Capecitabine Celecoxib (Cele... Temozolomide Lomustine 6-Thioguanine | 12 Years - | M.D. Anderson Cancer Center | |
| Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma | NCT01605162 | Wild Type BRAF ... Unresectable St... | TMZ E7016 | 18 Years - | Eisai Inc. | |
| Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme | NCT05589961 | Glioblastoma Mu... | TMZ | 18 Years - 75 Years | The Second Hospital of Hebei Medical University | |
| Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma | NCT00715793 | Malignant Melan... | Decitabine Temozolomide biopsy | 18 Years - | University of Pittsburgh | |
| T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery | NCT03190967 | Breast Cancer Brain Metastasi... Brain Cancer | T-DM1 TMZ | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer | NCT01506609 | Metastatic Brea... | Placebo Veliparib Carboplatin Temozolomide Paclitaxel | 18 Years - | AbbVie | |
| Nuvigil or Placebo in Newly Diagnosed Malignant Glioma | NCT01400958 | Malignant Gliom... | Nuvigil® Placebo | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients | NCT00526617 | Non-hematologic... Metastatic Mela... Breast Cancer Ovarian Cancer Primary Periton... Fallopian Tube ... Hepatocellular ... | ABT-888 Temozolomide | 18 Years - | AbbVie | |
| Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma | NCT01260103 | Optic Nerve Gli... | Temozolomide ANP Therapy | 6 Months - 18 Years | Burzynski Research Institute | |
| Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma | NCT00895960 | Glioblastoma CNS Disease Brain Diseases | Dasatinib RT (Radiotherap... TMZ (Temozolomi... | 18 Years - | M.D. Anderson Cancer Center | |
| ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer | NCT01009788 | Breast Cancer Metastatic Brea... BRCA1 Gene Muta... brca2 Gene Muta... | ABT-888 temozolomide | 18 Years - | Massachusetts General Hospital | |
| Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer | NCT03879811 | Colorectal Canc... | TMZ Nivolumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Nuvigil or Placebo in Newly Diagnosed Malignant Glioma | NCT01400958 | Malignant Gliom... | Nuvigil® Placebo | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| LAM561 With RT and TMZ for Adults With Glioblastoma | NCT04250922 | Primary Gliobla... Glioblastoma Mu... | LAM561 TMZ RT | 18 Years - 75 Years | Laminar Pharmaceuticals | |
| LAM561 With RT and TMZ for Adults With Glioblastoma | NCT04250922 | Primary Gliobla... Glioblastoma Mu... | LAM561 TMZ RT | 18 Years - 75 Years | Laminar Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
